| abstract |
In one aspect, the present invention provides compounds (II), compositions, and methods for administering compounds and compositions to a patient in need thereof. In another aspect, the invention relates to compounds and compositions for the treatment of cancer, for example lymphoid leukemia. The invention further provides compounds that inhibit two phosphoinositide 3-kinase (PI3K) isoforms, y and δ, pharmaceutical compositions comprising said compounds, and methods of using the compounds and pharmaceutical compositions for the treatment, attenuation and / or prevention of non-Hodgkin's lymphoma. |